These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20888084)

  • 21. Escape from flatland: increasing saturation as an approach to improving clinical success.
    Lovering F; Bikker J; Humblet C
    J Med Chem; 2009 Nov; 52(21):6752-6. PubMed ID: 19827778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural product-like libraries based on non-aromatic, polycyclic motifs.
    Messer R; Fuhrer CA; Häner R
    Curr Opin Chem Biol; 2005 Jun; 9(3):259-65. PubMed ID: 15939327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biocatalysis: synthesis of chiral intermediates for drugs.
    Patel RN
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):741-64. PubMed ID: 17117684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural products as leads to potential drugs: an old process or the new hope for drug discovery?
    Newman DJ
    J Med Chem; 2008 May; 51(9):2589-99. PubMed ID: 18393402
    [No Abstract]   [Full Text] [Related]  

  • 25. Natural product-like chemical space: search for chemical dissectors of macromolecular interactions.
    Reayi A; Arya P
    Curr Opin Chem Biol; 2005 Jun; 9(3):240-7. PubMed ID: 15939325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expanding the ChemGPS chemical space with natural products.
    Larsson J; Gottfries J; Bohlin L; Backlund A
    J Nat Prod; 2005 Jul; 68(7):985-91. PubMed ID: 16038536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prioritization of anti-malarial hits from nature: chemo-informatic profiling of natural products with in vitro antiplasmodial activities and currently registered anti-malarial drugs.
    Egieyeh SA; Syce J; Malan SF; Christoffels A
    Malar J; 2016 Jan; 15():50. PubMed ID: 26823078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and properties of allenic natural products and pharmaceuticals.
    Hoffmann-Röder A; Krause N
    Angew Chem Int Ed Engl; 2004 Feb; 43(10):1196-216. PubMed ID: 14991780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthetic approaches to the 2010 new drugs.
    Liu KK; Sakya SM; O'Donnell CJ; Flick AC; Ding HX
    Bioorg Med Chem; 2012 Feb; 20(3):1155-74. PubMed ID: 22261026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FOG: Fragment Optimized Growth algorithm for the de novo generation of molecules occupying druglike chemical space.
    Kutchukian PS; Lou D; Shakhnovich EI
    J Chem Inf Model; 2009 Jul; 49(7):1630-42. PubMed ID: 19527020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicity versus potency: elucidation of toxicity properties discriminating between toxins, drugs, and natural compounds.
    Struck S; Schmidt U; Gruening B; Jaeger IS; Hossbach J; Preissner R
    Genome Inform; 2008; 20():231-42. PubMed ID: 19425137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Libraries from natural product-like scaffolds.
    Boldi AM
    Curr Opin Chem Biol; 2004 Jun; 8(3):281-6. PubMed ID: 15183326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Model-free drug-likeness from fragments.
    Ursu O; Oprea TI
    J Chem Inf Model; 2010 Aug; 50(8):1387-94. PubMed ID: 20726597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Chemometric Analysis of Deep-Sea Natural Products.
    Pilkington LI
    Molecules; 2019 Oct; 24(21):. PubMed ID: 31683674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereoselective heterocycle synthesis through oxidative carbon-hydrogen bond activation.
    Liu L; Floreancig PE
    Curr Opin Drug Discov Devel; 2010; 13(6):733-47. PubMed ID: 21061234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting blood-brain barrier penetration of drugs using an artificial neural network.
    Fu XC; Wang GP; Liang WQ; Yu QS
    Pharmazie; 2004 Feb; 59(2):126-30. PubMed ID: 15025181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bridging chemical and biological space: "target fishing" using 2D and 3D molecular descriptors.
    Nettles JH; Jenkins JL; Bender A; Deng Z; Davies JW; Glick M
    J Med Chem; 2006 Nov; 49(23):6802-10. PubMed ID: 17154510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time-related differences in the physical property profiles of oral drugs.
    Leeson PD; Davis AM
    J Med Chem; 2004 Dec; 47(25):6338-48. PubMed ID: 15566303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthetic approaches to the 2009 new drugs.
    Liu KK; Sakya SM; O'Donnell CJ; Flick AC; Li J
    Bioorg Med Chem; 2011 Feb; 19(3):1136-54. PubMed ID: 21256756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular properties that influence oral drug-like behavior.
    Lajiness MS; Vieth M; Erickson J
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):470-7. PubMed ID: 15338956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.